$NATR

e.l.f. Beauty (NYSE:ELF) Q2 earnings: leading the personal care pack

Nature's Sunshine (NATR) reported $117M revenue, up 1.9% YoY, missing estimates. Herbalife (HLF) reported $1.33B revenue, up 5.4%, beating expectations. Estée Lauder (EL) reported $3.64B revenue, up 6.8%, surpassing estimates. NATR stock fell 38.9%, HLF rose 9.4%, EL gained 27.2% post-earnings.

Original reporting
Published Oct 24, 2026, 2:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 24, 2026, 2:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
e.l.f. Beauty (NYSE:ELF) Q2 earnings: leading the personal care pack — source image
Decision brief

The 30-second read

$NATRBearishLow
01

Why it matters

No new data beyond the original earnings releases; the piece is a recap.

02

Market read

Recap of earnings with existing price moves; limited actionable insight.

03

What to watch

Supply‑chain pressures and macro consumer spending trends could affect future quarters.

Relevance 4/10Novelty 2/10Timing: none

Background

The article summarizes Q2 earnings for three personal‑care companies, all previously released.

Company-level read

Ticker impact

$NATRBearishHigh confidence
Context

Nature's Sunshine Q2 results recited, stock down 38.9% after earnings miss.

Expected impact

likely further downside as market prices in the earnings miss

Evidence & confidence

Earnings miss and guidance downgrade already drove a 38.9% drop; no new catalyst to reverse.

$HLFBullishHigh confidence
Context

Herbalife Q2 results recited, stock up 9.4% after earnings beat.

Expected impact

potential modest rally as investors digest the beat

Evidence & confidence

Earnings beat already lifted the stock; no further catalyst, but momentum may persist briefly.

$ELBullishHigh confidence
Context

Estée Lauder Q2 results recited, stock up 27.2% after strong earnings.

Expected impact

likely further upside in the near term

Evidence & confidence

Robust beat already sparked a 27% gain; short‑term momentum may continue.

Market effects

Personal care sector shows mixed performance; weak players drag while leaders rally.

U.S. consumer discretionary sentiment remains split.

Limited; reflects company‑specific earnings recaps.

Counterpoint

Despite recent gains, valuation may be stretched for Herbalife and Estée Lauder.

Key entities

  • Nature's Sunshine

    Nutritional and personal care products maker.

  • Herbalife

    Weight‑management and nutrition products company.

  • Estée Lauder

    Beauty and cosmetics conglomerate.

Related articles

$ELLow

Judge Awards $63 Million in Fees From Estée Lauder Investor Settlement

A U.S. judge approved Estée Lauder's $210M investor settlement, setting attorneys' fees at $63M (30% of the fund). The court also approved $759,672.80 in litigation expenses and $21,995.21 in reimbursements. The settlement resolves claims of misleading shareholders about growth outlook and reliance on gray-market sales in China. The company denies wrongdoing.

$ELHighAI 9/10

Ban maker's shares jump on strong eyewear sales

EssilorLuxottica shares rose 14% after Q3 revenue of €7.49B beat expectations, driven by strong core eyewear sales. Smart glasses growth slowed, and the company provided a cautious outlook. Analysts note attractive valuations and defensive attributes, despite concerns over smart glasses competition.

$ELMed

Why is Estee Lauder stock climbing today?

Estee Lauder (EL) stock rose 2.6% in pre-market trading after Barclays upgraded it to Overweight and raised its price target to $108, citing broad recovery and strong Q4 2026 results. The company reported adjusted EPS of $0.39 and revenue of $3.63B, both beating estimates. Barclays highlighted balanced revenue growth and margin expansion potential. Bernstein SocGen maintained a Market Perform rating with a $106 target. The broader market traded modestly lower.